Latest filing published 13 Aug 2026 for Rocket Pharmaceuticals, INC., €14k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Sarbani Chaudhuri: trading record in brief
Sarbani Chaudhuri discloses dealings in Rocket Pharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 11 February 2026 to 11 August 2026.
No open-market purchase appears, only 1 sale worth €14k. Other entries cover 1 share grant.
The newest entry dates from 13 August 2026: an open-market sale of €14k, in Rocket Pharmaceuticals, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sarbani Chaudhuri
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,701 shares@ US$3.499Common StockSEC:0001140361-26-032816:0
- 125,924 shares0Common StockSEC:0001140361-26-005407:0
2 of 2 declarations
